CTI 222 Pill — WHITE ROUND, 11mm — Ciprofloxacin
| Imprint | CTI / 222 |
|---|---|
| Colour | WHITE |
| Shape | ROUND |
| Size | 11 |
| Strength | CIPROFLOXACIN HYDROCHLORIDE 250 mg |
| Dosage form | Tablet, Film Coated |
| Manufacturer | Carlsbad Technology, Inc. |
| NDC | 61442-222 |
| Schedule | — |
| Availability | Prescription only |
| Ingredients | CIPROFLOXACIN HYDROCHLORIDE[CIPROFLOXACIN] |
What does this imprint mean?
The imprint "CTI 222" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.
Active ingredient
Ciprofloxacin
Uses and warnings
BOXED WARNING: BOXED WARNING: Fluoroquinolones including ciprofloxacin are "associated with disabling and potentially irreversible serious adverse reactions" including tendinitis/tendon rupture, peripheral neuropathy, and central nervous system effects occurring together. The drug may exacerbate muscle weakness in myasthenia gravis patients and should be avoided in that population. Key Warnings: - Discontinue immediately upon experiencing serious adverse reactions - Risk of tendon rupture (especially Achilles tendon), particularly in patients over 60, on corticosteroids, or with organ transplants - Peripheral neuropathy with potentially irreversible symptoms - CNS effects: psychiatric reactions, seizures, hallucinations, depression with suicidal ideation - Serious hypersensitivity/anaphylactic reactions possible - Hepatotoxicity including fatal hepatic failure reported - QT interval prolongation and torsade de pointes risk - Aortic aneurysm and dissection risk in elderly patients - C. difficile-associated diarrhea possible | BOXED WARNING: Fluoroquinolones including ciprofloxacin are "associated with disabling and potentially irreversible serious adverse reactions" including tendinitis/tendon rupture, peripheral neuropathy, and central nervous system effects occurring together. The drug may exacerbate muscle weakness in myasthenia gravis patients and should be avoided in that population. Key Warnings: - Discontinue immediately upon experiencing serious adverse reactions - Ris
Ciprofloxacin tablets are a fluoroquinolone antibacterial indicated in adults (18+ years) and select pediatric patients for treating infections including: skin/skin structure infections, bone and joint infections, complicated intra-abdominal infections, infectious diarrhea, typhoid fever, uncomplicated gonorrhea, inhalational anthrax post-exposure, plague, chronic bacterial prostatitis, lower respiratory tract infections, urinary tract infections, and acute sinusitis. The label emphasizes reserving use for patients with no alternative treatment options for certain conditions like acute uncomplicated cystitis and acute bronchitis exacerbations due to serious adverse risks.
How to identify this pill
- • Check the imprint matches exactly: "CTI 222".
- • Confirm the colour (WHITE) and shape (ROUND).
- • Compare the size (11) against a ruler if possible.
- • When in doubt, confirm with a pharmacist before taking any medication.
Similar-looking pills
IP46
WHITE ROUND · Cetirizine
61 61
WHITE ROUND · Trazodone
FR11
WHITE ROUND · Acetaminophen
703
WHITE ROUND · Phentermine
16 G
WHITE ROUND · Estradiol
HP 27
WHITE ROUND · Verapamil
RC17
WHITE ROUND · Loratadine
R 20
WHITE ROUND · Sildenafil
458 Claritin10
WHITE ROUND · Loratadine
A101
WHITE ROUND · Bupropion
14
WHITE ROUND · Olanzapine
G 25
WHITE ROUND · Topiramate
Other pills of Ciprofloxacin
WW929
WHITE CAPSULE · Ciprofloxacin
C 94
WHITE OVAL · Ciprofloxacin
M 1745
ORANGE OVAL · Ciprofloxacin
C 94
WHITE CAPSULE · Ciprofloxacin
T92
WHITE ROUND · Ciprofloxacin
WW928
WHITE CAPSULE · Ciprofloxacin
CF 250
WHITE ROUND · Ciprofloxacin
G CF
WHITE OVAL · Ciprofloxacin
Y102
WHITE OVAL · Ciprofloxacin
C 93
WHITE CAPSULE · Ciprofloxacin
WW927
WHITE ROUND · Ciprofloxacin
WW928
WHITE CAPSULE · Ciprofloxacin
Official references
Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 592f5504-fe8f-36e4-e053-2991aa0a2347.xml